ProCE Banner Activity

Interview With the Experts: Strategies to Overcome SDOH in NVAF Part 1

Podcast Episodes

In this podcast, David S. Kountz, MD, interviews Keith C. Ferdinand MD, FACC, FAHA, about a patient case in which social determinants of health (SDOH) affected nonvalvular atrial fibrillation (NVAF) management. Listen as Dr. Ferdinand and Dr. Kountz provide specific strategies to implement to address low health literacy and patient access to direct-acting oral anticoagulant to improve patient outcomes in NVAF.

In Collaboration With the Academy of Physician Associates in Cardiology


Released: June 03, 2022

Expiration: June 02, 2023



Keith C. Ferdinand

Keith C. Ferdinand, MD, FACC, FAHA

Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

David S. Kountz

David S. Kountz, MD, MBA, MACP

Department of Medicine
Hackensack Meridian School of Medicine
Nutley, New Jersey


This activity is supported by an educational grant from the Bristol-Myers Squibb and Pfizer Alliance.

Provided by

ProCE Banner
ProCE Banner


This activity is supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance.

Bristol Myers Squibb

Pfizer Alliance



ProCE Banner

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify SDOH that affect outcomes in CV and NVAF management

  • Apply strategies to address SDOH in clinical practice to improve the management of NVAF


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Keith C. Ferdinand, MD, FACC, FAHA: has disclosed that he has received consulting fees from Amgen, Boehringer Ingelheim, Medtronic, Novartis, and Sanofi.

David S. Kountz, MD has no relevant conflicts of interest to report.

Darcy Theisen, NP has no relevant conflicts of interest to report.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.